Torus Biosystems Email Format
Biotechnology ResearchMassachusetts, United States2-10 Employees
Torus Biosystems is a biotechnology company focused on rapid detection of DNA and RNA for clinical use. It was founded in 2020 as a spin-out from Harvard University’s Wyss Institute, to develop and commercialize a proprietary detection technology created by Peng Yin and David Zhang. The company is based in Medford, Massachusetts. Its work supports improved patient outcomes and antimicrobial stewardship in ambulatory care settings, including hospital outpatient and emergency departments as well as long-term care facilities. Its position lies in the biotechnology research industry, translating academic innovations into clinically usable diagnostics for healthcare providers. In 2024, Torus announced a collaboration with Tata Sons Limited to advance healthcare solutions.